Selective inhibition by fenflumizole tissue cyclooxygenase in rabbits ex vivo
- PMID: 3929239
Item in Clipboard
Selective inhibition by fenflumizole tissue cyclooxygenase in rabbits ex vivo
Pol J Pharmacol Pharm.
1985 Jan-Feb.
Abstract
A new non-steroidal anti-inflammatory drug fenflumizole when administered orally to rabbits at therapeutic doses of 10 and 30 mg/kg affects neither PGI2 generation by arterial slices nor PGE2 generation by gastric mucosa, respectively. Fenflumizole at doses of 10 and 30 mg/kg per os inhibits platelet aggregability and generation of TXA2 by platelets. It is suggested that this selective action of fenflumizole on tissue cyclooxygenase ex vivo may justify with fenflumizole in anti-thrombotic therapy.
Similar articles
-
Fenflumizole: interactions with the arachidonic acid cascade.Acta Pharmacol Toxicol (Copenh). 1983 Oct;53(4):297-303. doi: 10.1111/j.1600-0773.1983.tb03426.x. Acta Pharmacol Toxicol (Copenh). 1983. PMID: 6417973
-
Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.Drugs Exp Clin Res. 1993;19(6):249-60. Drugs Exp Clin Res. 1993. PMID: 8013268
-
[The prostaglandin and thromboxane system of the gastric mucosa as a target for protective and ulcerogenic drugs].Wien Klin Wochenschr. 1984 Feb 17;96(4):133-8. Wien Klin Wochenschr. 1984. PMID: 6585091 German.
-
[Pharmacology of anti-platelet agents].J Mal Vasc. 1983;8(1):3-16. J Mal Vasc. 1983. PMID: 6302191 Review. French.
-
Effects of non-steroidal anti-inflammatory drugs on the in vivo synthesis of thromboxane and prostacyclin in humans.Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:153-6. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1825533 Review.